Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Series A Preferred Stock	Series A Preferred Stock Preferred Stock
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2021							0
Beginning balance at Dec. 31, 2021	$ 478,047	$ 42	$ 585,397	$ (282)	$ (107,110)		$ 0
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2021		41,817,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued as consideration for SciSafe earnout (in shares)		64,130
Stock issued as consideration for SciSafe earnout	817		817
Fees incurred for registration filings	(131)		(131)
Stock-based compensation	25,334		25,334
Stock option exercises (in shares)		161,646
Stock option exercises	323		323
Stock issued – on vested RSAs (in shares)		788,952
Stock issued – on vested RSAs	0	$ 1	(1)
Other comprehensive income (loss)	(397)			(397)
Net loss	(139,805)				(139,805)
Ending balance, preferred stock, outstanding (in shares) at Dec. 31, 2022							0
Ending balance at Dec. 31, 2022	364,188	$ 43	611,739	(679)	(246,915)		$ 0
Ending balance, common stock, outstanding (in shares) at Dec. 31, 2022		42,832,231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued as consideration for SciSafe earnout (in shares)		116,973
Stock issued as consideration for SciSafe earnout	2,263		2,263
Fees incurred for registration filings	(132)		(132)
Stock-based compensation	33,245		33,245
Stock option exercises (in shares)		239,043
Stock option exercises	507		507
Stock issued – on vested RSAs (in shares)		1,267,837
Stock issued – on vested RSAs	0	$ 1	(1)
Settlement of Global Cooling escrow (in shares)		(216,024)
Settlement of Global Cooling escrow	(5,115)		(5,115)
Common stock shares issued (in shares)		927,165
Common stock shares issued	10,375	$ 1	10,374
Other comprehensive income (loss)	334			334
Net loss	(68,002)				(68,002)
Ending balance, preferred stock, outstanding (in shares) at Dec. 31, 2023						0	0
Ending balance at Dec. 31, 2023	$ 337,663	$ 45	652,880	(345)	(314,917)		$ 0
Ending balance, common stock, outstanding (in shares) at Dec. 31, 2023	45,167,225	45,167,225
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued as consideration for SciSafe earnout	$ 0
Stock-based compensation	30,923		30,923
Stock option exercises (in shares)		90,250
Stock option exercises	202		202
Stock issued – on vested RSAs (in shares)		1,649,290
Stock issued – on vested RSAs	(64)	$ 2	(66)
Other comprehensive income (loss)	369			369
Net loss	(20,184)				(20,184)
Ending balance, preferred stock, outstanding (in shares) at Dec. 31, 2024						0	0
Ending balance at Dec. 31, 2024	$ 348,909	$ 47	$ 683,939	$ 24	$ (335,101)		$ 0
Ending balance, common stock, outstanding (in shares) at Dec. 31, 2024	46,906,765	46,906,765